ArticleNeurology2026

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Dror Shir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.